This book covers the scope of current knowledge of cancer in the LGBT community across the entire cancer continuum, from understanding risk and prevention strategies in LGBT groups, across issues of diagnosis and treatment of LGBT patients, to unique aspects of survivorship and death and dying in these communities. Each chapter includes an in depth analysis of the state of the science, discusses the many remaining challenges and unanswered questions and makes recommendations for research, policy and programmatic strategies required to address these. Focus is also placed on the diversity of the LGBT communities. Issues that are unique to cancer in LGBT populations are addressed including the social, economic and cultural factors that affect cancer risk behaviors, barriers to screening, utilization of health care services, and legislation that directly impacts the health care of LGBT patients, healthcare settings that are heterosexist and unique aspects of patient-provider relationships such as disclosure of sexual orientation and the need for inclusion of expanded definition of family to include families of choice. The implications of policy change, its impact on healthcare for LGBT patients are highlighted, as are the remaining challenges that need to be addressed. A roadmap for LGBT cancer prevention, detection, diagnosis, survivorship, including treatment and end of life care is offered for future researchers, policy makers, advocates and health care providers.

Lesbian, Gay, Bisexual, and Transgender (LGBT) also known as sexual and gender minority (SGM) populations have been the focus of global attention. Most importantly, LGBT populations have been addressed in the context of human rights in multiple reports and other activities by the United Nations and other international organizations. There is great variation among countries in the recognition of LGBT individuals' human rights. A global focus on LGBT populations' health is still limited, with the notable exception of HIV research. This book on LGBT populations and cancer in the global context is, therefore, an important step in that it will broaden the focus on LGBT populations' health. Globally, cancer is the second leading cause of death. Cancer morbidity and mortality are increasing disproportionately among populations in lower-income countries. A review conducted by the World Health Organization (WHO) found that of the 82% of member states (158) countries, only 35% of the national cancer control plans addresses vulnerable population, including LGBT populations. These findings reflect an increasing awareness about equity when addressing cancer prevention and control, including LGBT populations. This book addresses LGBT populations' cancer burden across countries that range from high- to low-income countries to support efforts in diverse countries that are working towards reducing LGBT populations' cancer burden. It documents place-specific challenges that impede progress towards reducing the LGBT cancer burden as well as critically assesses the variation in cancer control efforts that target LGBT populations and cancer to support progress at a global scale. This book includes six sections that cover the six WHO regions, with each chapter written by an author from the specific region s/he is covering. Each chapter makes use of a template that contextualizes the region, local data collection/availability, risk factors, cancer prevention, detection, diagnosis, treatment, and survivorship.

This book covers the scope of current knowledge of cancer in the LGBT community across the entire cancer continuum, from understanding risk and prevention strategies in LGBT groups, across issues of diagnosis and treatment of LGBT patients, to unique aspects of survivorship and death and dying in these communities. Each chapter includes an in depth analysis of the state of the science, discusses the many remaining challenges and unanswered questions and makes recommendations for research, policy and programmatic strategies required to address these. Focus is also placed on the diversity of the LGBT communities. Issues that are unique to cancer in LGBT populations are addressed including the social, economic and cultural factors that affect cancer risk behaviors, barriers to screening, utilization of health care services, and legislation that directly impacts the health care of LGBT patients, healthcare settings that are heterosexist and unique aspects of patient-provider relationships such as disclosure of sexual orientation and the need for inclusion of expanded definition of family to include families of choice. The implications of policy change, its impact on healthcare for LGBT patients are highlighted, as are the remaining challenges that need to be addressed. A roadmap for LGBT cancer prevention, detection, diagnosis, survivorship, including treatment and end of life care is offered for future researchers, policy makers, advocates and health care providers.